How does octreotide work in carcinoid crisis?

How does octreotide work in carcinoid crisis?

Octreotide is a synthetic version of somatostatin (a somatostatin analogue) and slows down the production of hormones. This helps to control the symptoms of carcinoid syndrome and slow down the growth of the cancer.

Why does octreotide treat carcinoid?

The drug most commonly used to treat carcinoid tumors is octreotide (Sandostatin). This drug is similar to a hormone that occurs naturally in the body. It can help relieve the flushing and diarrhea caused by carcinoid syndrome, and slow tumor growth.

How is carcinoid crisis treated?

Treatment

1. Surgery. Surgery to remove your cancer or most of your cancer may be an option.
2. Medications to block cancer cells from secreting chemicals.
3. Drugs that deliver radiation directly to the cancer cells.
4. Stopping blood supply to liver tumors.
5. Killing cancer cells in the liver with heat or cold.
6. Chemotherapy.

How can carcinoid crisis be prevented?

To protect against a carcinoid crisis during surgery, a patient should be treated with a somatostatin analog, such as Octreotide, either before and/or during the procedure. Octreotide is usually administered by intravenous infusion if the procedure is prolonged.

Does octreotide shrink tumors?

Octreotide is helpful in treating the symptoms of carcinoid syndrome. Sometimes octreotide can temporarily shrink carcinoid tumors, but it does not cure them. The original version of octreotide (Sandostatin®) is injected under the skin (subcutaneously) at least twice daily.

What is an Octreoscan test?

An octreotide scan (also called a somatostatin receptor scintigraphy) is a test used to check the body for neuroendocrine tumor cells. This test is done in a Nuclear Medicine department, which is a type of radiology that uses radioactive materials to diagnose or treat diseases.

How is an Octreoscan performed?

To detect these tumours, a small amount of harmless medication, a radiopharmaceutical (see InsideRadiology: Nuclear Medicine), is injected into a vein in the arm, followed by a whole-body scan to take pictures or images. The same images are also taken the next day, but no further injection is given on the second visit.

How to administer octreotide?

Octreotide may be administered directly by subcutaneous (s.c.) injection or by intravenous (i.v.) infusion after dilution. For further instructions on handling and instructions for dilution of the medicinal product, refer to section 6.6. Known hypersensitivity to the active substance or to any of the excipients listed in section 6.1.

Where to inject octreotide subcutaneously?

Short-acting octreotide is injected under the skin ( subcutaneous) of the hip, thigh, or abdomen 2 to 4 times daily. Long-lasting octreotide is injected by a health care professional into the gluteal muscle (the buttocks) every 4 weeks. When used to treat bleeding in the esophagus and stomach, octreotide is given intravenously (into a vein).

How to administer subcutaneous octreotide?

Octreotide comes as an immediate-release injection to be injected subcutaneously (under the skin) or intravenously (into a vein) and as a long-acting injection to be injected into the muscles of the buttocks by a doctor or nurse. Octreotide immediate-release injection is usually injected 2 to 4 times a day.

Is octreotide a chemotherapy drug?

Octreotide is a synthetic analog of the hormone, somatostatin (NO relationship to a “statin” drug). “Chemo” usually refers to some toxic anti-metabolite that leads to arrest of cell division and/or cell death.